Premium
Breast cancer incidence in the regions of Belarus and Ukraine most contaminated by the Chernobyl accident: 1978 to 2016
Author(s) -
Zupunski Ljubica,
Yaumenenka Alesia,
Ryzhov Anton,
Veyalkin Ilya,
Drozdovitch Vladimir,
Masiuk Sergii,
Ivanova Olha,
Kesminiene Ausrele,
Pukkala Eero,
Moiseev Pavel,
Prysyazhnyuk Anatoly,
Schüz Joachim,
Ostroumova Evgenia
Publication year - 2020
Publication title -
international journal of cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.475
H-Index - 234
eISSN - 1097-0215
pISSN - 0020-7136
DOI - 10.1002/ijc.33346
Subject(s) - breast cancer , incidence (geometry) , medicine , population , cumulative incidence , demography , cancer , epidemiology , chernobyl nuclear accident , nuclear medicine , environmental health , cohort , physics , optics , sociology
Even 30 years after the accident, an association between breast cancer incidence and ionizing radiation exposure from Chernobyl fallout remains uncertain. We studied breast cancer incidence in the most contaminated regions of Belarus (Gomel and Mogilev) and Ukraine (Kyiv, Zhytomyr and Chernihiv) before (1978‐1986) and after (1987‐2016) the accident. Breast cancer cases and female population size data were received from the national cancer registries and the state departments of statistics. The study included 85 132 breast cancers with 150 million person‐years at risk. We estimated annual rayon (district)‐average absorbed doses to the breast from external and internal irradiation of the adult female population over the period of 1986‐2016. We studied an association between rayon‐average cumulative absorbed breast dose with 5‐year lag, that is, excluding the exposure in 5 years prior to breast cancer diagnosis, and breast cancer incidence using negative binomial regression models. Mean (median) cumulative breast dose in 2016 was 12.3 (5.0) milligray (mGy) in Belarus and 5.7 (2.3) mGy in Ukraine, with the maximum dose of 55 mGy and 54 mGy, respectively. Breast cancer incidence rates statistically significantly increased with calendar year and attained age, and were higher in urban than in rural residents. Adjusting for time, age and urbanicity effects, we found no evidence of increasing incidence with rayon‐average 5‐year lagged cumulative breast dose. Owing to ecological study design limitations, a case‐control study covering this area with individually reconstructed absorbed breast doses is needed testing for association between low‐dose protracted radiation exposure and breast cancer risk after Chernobyl.